Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Delayed Data from NYSE)

$7.12 USD

7.12
2,671,487

+0.23 (3.34%)

Updated Jun 7, 2024 04:00 PM ET

After-Market: $7.12 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (91 out of 248)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for MD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Pediatrix Medical Group, Inc. [MD]

Reports for Purchase

Showing records 241 - 260 ( 341 total )

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 241

11/05/2012

Company Report

Pages: 8

3Q Beats By $0.05. 4Q Guidance Well Above Consensus. Reimbursement Parity Will Help In 2013, 2014. Anesthesia Acceleration Just Beginning. Expect Breakout Year In 2013. Affirm Buy Rating And $95 PT.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 242

11/05/2012

Company Report

Pages: 6

Q3/2012 - Another positive surprise

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 243

11/02/2012

Company Report

Pages: 7

Better than expected results; CMS finalizes Medicaid parity, estimates to increase

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 244

10/31/2012

Company Report

Pages: 9

Preliminary low weight birth data reflects solid 3Q12 trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 245

09/20/2012

Company Report

Pages: 8

Investor Meeting Highlights Anesthesia Opportunity. Acceleration Just Beginning. Expect Breakout .

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 246

09/20/2012

Company Report

Pages: 7

Analyst Day sets the stage for national anesthesia presence

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 247

08/03/2012

Company Report

Pages: 6

MD Q2/12 Surprise on upside, Acquisition activity picks up Maintain Buy and $80.00 price target

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 248

08/01/2012

Company Report

Pages: 8

MD Better than expected results inline with our propriety research; raising estimates

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 249

08/01/2012

Company Report

Pages: 8

MD: Solid 2Q. Anesthesia To Accelerate. Reimbursement To Increase. Affirm Buy And Raise PT To $95.

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 250

07/26/2012

Company Report

Pages: 8

Preliminary birth weight data suggests improving Pediatrix trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 251

07/13/2012

Company Report

Pages: 8

ACA Should Result In Favorable Reimbursement. Also Expect Anesthesia Acceleration To Contribute To Faster Growth. Affirm Buy Rating And $80 PT.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 252

07/05/2012

Daily Note

Pages: 6

2H:2012 Top Ideas

Provider: FELTL & COMPANY

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 253

05/21/2012

Company Report

Pages: 6

MD: Q1/2012 results in line; Maintain Buy

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 254

05/07/2012

Company Report

Pages: 8

MD: 2Q To Be Soft. Expect Anesthesia Acceleration To Drive Growth.Affirm Buy Rating. Reducing PT From $100 To $80.

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 255

05/04/2012

Company Report

Pages: 8

1Q12 results below expectations as margins get squeezed

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 256

02/06/2012

Company Report

Pages: 7

MD: 4Q In Line. Anesthesia Acceleration Will Drive Growth. Affirm Buy Rating And Raise PT From $90 To $100.

Provider: COLLIERS SECURITIES

Analyst: CHAULAGAI D

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 257

02/03/2012

Company Report

Pages: 7

Mixed quarterly results; accelerating M&A pace to provide earnings upside?

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 258

02/01/2012

Company Report

Pages: 7

4Q11 Preview: Cautious on quarterly volumes; remain focused on stabilizing trends

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 259

11/08/2011

Company Report

Pages: 7

Anesthesia acquisition driving higher estimates and PT

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party

Company: Pediatrix Medical Group, Inc.

Industry: Medical - Hospital

Record: 260

11/02/2011

Company Report

Pages: 7

MD Strong 3Q results; expect M&A pace to accelerate

Provider: FELTL & COMPANY

Analyst: WEIGHT M

Price: 25.00

Research Provided by a Third Party